These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 17533125)

  • 1. Co-crystal structure guided array synthesis of PPARgamma inverse agonists.
    Trump RP; Cobb JE; Shearer BG; Lambert MH; Nolte RT; Willson TM; Buckholz RG; Zhao SM; Leesnitzer LM; Iannone MA; Pearce KH; Billin AN; Hoekstra WJ
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3916-20. PubMed ID: 17533125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2D QSAR of PPARgamma agonist binding and transactivation.
    Rücker C; Scarsi M; Meringer M
    Bioorg Med Chem; 2006 Aug; 14(15):5178-95. PubMed ID: 16650995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of novel oxazole containing 1,3-dioxane-2-carboxylic acid derivatives as PPAR alpha/gamma dual agonists.
    Pingali H; Jain M; Shah S; Makadia P; Zaware P; Goel A; Patel M; Giri S; Patel H; Patel P
    Bioorg Med Chem; 2008 Aug; 16(15):7117-27. PubMed ID: 18625559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in the epithelial sodium channel associate with oedema in type 2 diabetic patients receiving the peroxisome proliferator-activated receptor gamma agonist farglitazar.
    Spraggs C; McCarthy A; McCarthy L; Hong G; Hughes A; Lin X; Sathe G; Smart D; Traini C; Van Horn S; Warren L; Mosteller M
    Pharmacogenet Genomics; 2007 Dec; 17(12):1065-76. PubMed ID: 18004211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids.
    Waku T; Shiraki T; Oyama T; Fujimoto Y; Maebara K; Kamiya N; Jingami H; Morikawa K
    J Mol Biol; 2009 Jan; 385(1):188-99. PubMed ID: 18977231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Modeling Approach to Study the PPARγ-Ligand Interactions.
    Al Sharif M; Tsakovska I; Alov P; Vitcheva V; Diukendjieva A; Pajeva I
    Methods Mol Biol; 2019; 1966():261-289. PubMed ID: 31041755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzoyl 2-methyl indoles as selective PPARgamma modulators.
    Acton JJ; Black RM; Jones AB; Moller DE; Colwell L; Doebber TW; Macnaul KL; Berger J; Wood HB
    Bioorg Med Chem Lett; 2005 Jan; 15(2):357-62. PubMed ID: 15603954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The differential interactions of peroxisome proliferator-activated receptor gamma ligands with Tyr473 is a physical basis for their unique biological activities.
    Einstein M; Akiyama TE; Castriota GA; Wang CF; McKeever B; Mosley RT; Becker JW; Moller DE; Meinke PT; Wood HB; Berger JP
    Mol Pharmacol; 2008 Jan; 73(1):62-74. PubMed ID: 17940191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 13-Oxo-ODE is an endogenous ligand for PPARgamma in human colonic epithelial cells.
    Altmann R; Hausmann M; Spöttl T; Gruber M; Bull AW; Menzel K; Vogl D; Herfarth H; Schölmerich J; Falk W; Rogler G
    Biochem Pharmacol; 2007 Aug; 74(4):612-22. PubMed ID: 17604003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activities of novel aryl indole-2-carboxylic acid analogs as PPARgamma partial agonists.
    Dropinski JF; Akiyama T; Einstein M; Habulihaz B; Doebber T; Berger JP; Meinke PT; Shi GQ
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5035-8. PubMed ID: 16153845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic action of peroxisome proliferator-activated receptor gamma agonism in rats with exogenous hypercorticosteronemia.
    Berthiaume M; Laplante M; Tchernof A; Deshaies Y
    Int J Obes (Lond); 2007 Nov; 31(11):1660-70. PubMed ID: 17579631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An innovative method to study target protein-drug interactions by mass spectrometry.
    Müller MQ; de Koning LJ; Schmidt A; Ihling C; Syha Y; Rau O; Mechtler K; Schubert-Zsilavecz M; Sinz A
    J Med Chem; 2009 May; 52(9):2875-9. PubMed ID: 19379014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of PPARgamma in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential.
    Yang J; Zhang D; Li J; Zhang X; Fan F; Guan Y
    Clin Sci (Lond); 2009 Jan; 116(1):17-26. PubMed ID: 19037881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of ORF4, a dominant negative variant of peroxisome proliferator-activated receptor gamma, in colorectal adenocarcinoma.
    Bouancheau D; Jarry A; Mottier S; Toquet C; Masson D; Mosnier JF; Laboisse CL; Denis MG
    Oncol Rep; 2007 Aug; 18(2):489-95. PubMed ID: 17611675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
    Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
    Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial agonists activate PPARgamma using a helix 12 independent mechanism.
    Bruning JB; Chalmers MJ; Prasad S; Busby SA; Kamenecka TM; He Y; Nettles KW; Griffin PR
    Structure; 2007 Oct; 15(10):1258-71. PubMed ID: 17937915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
    Kim KY; Ahn JH; Cheon HG
    Mol Pharmacol; 2007 Sep; 72(3):674-85. PubMed ID: 17535976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of natural ligands of PPARgamma on lipid metabolism in placental tissues from healthy and diabetic rats.
    Capobianco E; White V; Higa R; Martínez N; Jawerbaum A
    Mol Hum Reprod; 2008 Aug; 14(8):491-9. PubMed ID: 18621767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PPARgamma ligand rosiglitazone influences triacylglycerol metabolism in non-obese males, without increasing the transcriptional activity of PPARgamma in the subcutaneous adipose tissue.
    Joosen AM; Bakker AH; Kersten S; Westerterp KR
    Br J Nutr; 2008 Mar; 99(3):487-93. PubMed ID: 18177513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The many faces of PPARgamma: anti-inflammatory by any means?
    Szanto A; Nagy L
    Immunobiology; 2008; 213(9-10):789-803. PubMed ID: 18926294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.